AbbVie Inc. (ABBV) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbbVie Inc.

    NYSE: ABBV · Real-Time Price · USD
    209.94
    -2.62 (-1.23%)
    At close: Sep 08, 2025, 3:59 PM
    210.10
    0.08%
    After-hours: Sep 08, 2025, 07:57 PM EDT

    AbbVie Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 4.29B 4.82B 11.85B 11.55B
    Depreciation & Amortization
    		 8.39B 8.7B 8.47B 8.52B
    Stock-Based Compensation
    		 911M 747M 671M 692M
    Other Working Capital
    		 -2.85B -676M 278M -1.49B
    Other Non-Cash Items
    		 9.45B 8.6B 6.15B 4.24B
    Deferred Income Tax
    		 -1.45B -2.89B -1.93B -898M
    Change in Working Capital
    		 -2.78B 2.81B -258M -1.32B
    Operating Cash Flow
    		 18.81B 22.84B 24.94B 22.78B
    Capital Expenditures
    		 -974M -777M -695M -787M
    Cash Acquisitions
    		 -17.49B -1.22B -794M -1.9B
    Purchase of Investments
    		 -73M -77M -1.44B -119M
    Sales Maturities Of Investments
    		 555M 55M 1.53B 98M
    Other Investing Acitivies
    		 -2.83B 13M 774M 366M
    Investing Cash Flow
    		 -20.82B -2.01B -623M -2.34B
    Debt Repayment
    		 7.35B -4.15B -12.43B -8.41B
    Common Stock Repurchased
    		 -1.71B -1.97B -1.49B -934M
    Dividend Paid
    		 -11.03B -10.54B -10.04B -9.26B
    Other Financial Acitivies
    		 172M -562M -840M -430M
    Financial Cash Flow
    		 -5.21B -17.22B -24.8B -19.04B
    Net Cash Flow
    		 -7.29B 3.61B -545M 1.3B
    Free Cash Flow
    		 17.83B 22.06B 24.25B 21.99B

    Add to Watchlist